0.9719
Schlusskurs vom Vortag:
$0.9877
Offen:
$0.985
24-Stunden-Volumen:
19,388
Relative Volume:
0.02
Marktkapitalisierung:
$12.58M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-9.70M
KGV:
-0.8835
EPS:
-1.1
Netto-Cashflow:
$-8.57M
1W Leistung:
-4.73%
1M Leistung:
+2.26%
6M Leistung:
-21.88%
1J Leistung:
-73.32%
Marker Therapeutics Inc Stock (MRKR) Company Profile
Firmenname
Marker Therapeutics Inc
Sektor
Branche
Telefon
(713) 400-6400
Adresse
2450 HOLCOMBE BLVD, HOUSTON, TX
Vergleichen Sie MRKR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
MRKR
Marker Therapeutics Inc
|
0.9726 | 12.78M | 0 | -9.70M | -8.57M | -1.10 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.25 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
635.23 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
441.03 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
829.86 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.66 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Marker Therapeutics Inc Stock (MRKR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-05 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-03-25 | Eingeleitet | Piper Sandler | Overweight |
| 2021-03-19 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-05-12 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2019-05-30 | Eingeleitet | ROTH Capital | Buy |
| 2019-03-01 | Eingeleitet | Janney | Buy |
| 2018-12-03 | Hochstufung | Piper Jaffray | Neutral → Overweight |
Alle ansehen
Marker Therapeutics Inc Aktie (MRKR) Neueste Nachrichten
Reversal indicators forming on Marker Therapeutics Inc. stockGold Moves & Growth Focused Stock Pick Reports - newser.com
Visual analytics tools that track Marker Therapeutics Inc. performanceDay Trade & Weekly Market Pulse Updates - newser.com
What makes Marker Therapeutics Inc. (GX1) stock appealing to growth investorsTreasury Yields & Long-Term Growth Plans - newser.com
Technical signs of recovery in Marker Therapeutics Inc.2025 Breakouts & Breakdowns & Intraday High Probability Alerts - newser.com
Published on: 2025-11-02 15:53:33 - earlytimes.in
Does Marker Therapeutics Inc. fit your quant trading model2025 Top Decliners & Weekly Return Optimization Plans - newser.com
Is Marker Therapeutics Inc. reversing from oversold territoryWeekly Trend Report & Daily Profit Focused Stock Screening - newser.com
Is Marker Therapeutics Inc. (GX1) stock prepared for digital transitionWeekly Investment Report & Community Verified Swing Trade Signals - newser.com
Tools to assess Marker Therapeutics Inc.’s risk profileQuarterly Growth Report & Verified Trade Idea Suggestions - newser.com
Published on: 2025-10-29 06:15:46 - newser.com
Published on: 2025-10-29 03:27:17 - newser.com
Why Marker Therapeutics Inc. stock could outperform in 2025Exit Point & Real-Time Stock Movement Alerts - fcp.pa.gov.br
What catalysts could drive Marker Therapeutics Inc. stock higherQuarterly Market Summary & Daily Stock Trend Reports - fcp.pa.gov.br
Why Marker Therapeutics Inc. stock is trending among retail traders2025 Earnings Surprises & Risk Adjusted Swing Trade Ideas - fcp.pa.gov.br
Does Marker Therapeutics Inc. show high probability of reboundWeekly Loss Report & Free Growth Oriented Trading Recommendations - newser.com
Will Marker Therapeutics Inc. stock see insider buying2025 Bull vs Bear & Free Community Consensus Stock Picks - fcp.pa.gov.br
Is Marker Therapeutics Inc. stock near bottom after declineJuly 2025 Rallies & Low Risk Growth Stock Ideas - fcp.pa.gov.br
How forex fluctuations impact Marker Therapeutics Inc. (GX1) stockWeekly Investment Report & Stock Portfolio Risk Management - newser.com
Finanzdaten der Marker Therapeutics Inc-Aktie (MRKR)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):